Corrigendum to “pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease” [Eur. J. Pharm. Biopharm. 204 (2024) 114461] (European Journal of Pharmaceutics and Biopharmaceutics (2024) 204, (S093964112400287X), (10.1016/j.ejpb.2024.114461))

  • Sidra Altaf
  • , Mahira Zeeshan
  • , Hussain Ali
  • , Ahmed Zeb
  • , Iqra Afzal
  • , Ayesha Imran
  • , Danish Mazhar
  • , Salman Khan
  • , Fawad Ali Shah

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease” [Eur. J. Pharm. Biopharm. 204 (2024) 114461] (European Journal of Pharmaceutics and Biopharmaceutics (2024) 204, (S093964112400287X), (10.1016/j.ejpb.2024.114461))'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science